Call toll free: 800-411-1222
Se habla español.
More contact info
A Cohort Observational Study Evaluating the Incidence and Immunopathogenesis of Immune Reconstitution Syndrome (IRIS) in HIV-1 Infected Patients with CD4 Count less than or equal to 100 Cells/micro L who are Initiating Antiretroviral Therapy
The National Institutes of Health (NIH) is conducting a research study to evaluate patients who are initiating antiretroviral therapy (ART) for HIV to see if they develop conditions that may be related to immune reconstitution syndrome (IRIS). The purpose is to study what factors may lead to IRIS, what the outcome is after IRIS, and how to better define IRIS.
We will perform blood tests and monitor your treatment at study entry; then we will see you at 2 weeks, 4 weeks, 8 weeks and 12 weeks. After that, we will see you about every three months for the first year. We will see you about every four months after the first year, with the duration of the study being about four years in total. Volunteers will be compensated.
back to top
Last Updated October 26, 2011